Frédéric Mazurier Selected Research

Heme (Haem)

6/2008

[Successful gene therapy of mice with congenital erythropoietic porphyria].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frédéric Mazurier Research Topics

Disease

11	Neoplasms (Cancer) 05/2022 - 01/2010
7	Hypoxia (Hypoxemia) 01/2021 - 06/2007
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 12/2019
3	Xeroderma Pigmentosum (Kaposi's Disease) 01/2022 - 06/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2018
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 12/2019
2	Skin Neoplasms (Skin Cancer) 10/2019 - 01/2011
2	Inflammation (Inflammations) 12/2011 - 09/2011
2	Genomic Instability 06/2011 - 01/2011
2	Neutropenia 11/2006 - 01/2006
1	Carcinogenesis 01/2022
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 04/2019
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Adenocarcinoma 10/2018
1	Carcinoma (Carcinomatosis) 03/2017
1	Leukemia 01/2016
1	Metaplasia 02/2012
1	Atrophy 12/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011
1	Porphyrias (Porphyria) 06/2008
1	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 06/2008
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2005
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
4	Oxygen (Dioxygen)IBA 01/2016 - 06/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 06/2011
2	A-Form DNA (A-DNA)IBA 01/2022 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2021 - 07/2020
2	AcriflavineIBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 09/2011 - 06/2007
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2022
1	diphenyleneiodoniumIBA 05/2022
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2021
1	Differentiation AntigensIBA 01/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	bcr-abl Fusion ProteinsIBA 01/2021
1	NADP (NADPH)IBA 07/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2019
1	Calcium Channels (Calcium Channel)IBA 04/2019
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 04/2019
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 10/2018
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	Verapamil (Calan)FDA LinkGeneric 03/2017
1	Epithelial Cell Adhesion MoleculeIBA 03/2017
1	Green Fluorescent ProteinsIBA 02/2012
1	IntegrinsIBA 12/2011
1	Mitochondrial DNA (mtDNA)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2010
1	DNA Repair EnzymesIBA 01/2010
1	EnzymesIBA 06/2008
1	Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA 06/2008
1	Heme (Haem)IBA 06/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2006
1	Basic Helix-Loop-Helix Transcription FactorsIBA 10/2005
1	CytokinesIBA 07/2003

Therapy/Procedure

7	Therapeutics 01/2022 - 11/2006
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
1	Radiotherapy 03/2017
1	Subcutaneous Injections 01/2011
1	Transplantation 11/2006
1	Injections 11/2006
1	Autologous Transplantation 01/2006